Synaptogenix Stock Alpha and Beta Analysis

SNPX Stock  USD 4.14  0.02  0.48%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Synaptogenix. It also helps investors analyze the systematic and unsystematic risks associated with investing in Synaptogenix over a specified time horizon. Remember, high Synaptogenix's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Synaptogenix's market risk premium analysis include:
Beta
1.24
Alpha
(0.09)
Risk
4.35
Sharpe Ratio
(0.01)
Expected Return
(0.02)
Please note that although Synaptogenix alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., NYSE Composite index.) So in this particular case, Synaptogenix did 0.09  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Synaptogenix stock's relative risk over its benchmark. Synaptogenix has a beta of 1.24  . As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Synaptogenix will likely underperform. At this time, Synaptogenix's Book Value Per Share is fairly stable compared to the past year. Tangible Book Value Per Share is likely to rise to 57.64 in 2024, whereas Price Book Value Ratio is likely to drop 0.12 in 2024.
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Synaptogenix Backtesting, Synaptogenix Valuation, Synaptogenix Correlation, Synaptogenix Hype Analysis, Synaptogenix Volatility, Synaptogenix History and analyze Synaptogenix Performance.
For more information on how to buy Synaptogenix Stock please use our How to Invest in Synaptogenix guide.

Synaptogenix Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Synaptogenix market risk premium is the additional return an investor will receive from holding Synaptogenix long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Synaptogenix. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Synaptogenix's performance over market.
α-0.09   β1.24

Synaptogenix expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Synaptogenix's Buy-and-hold return. Our buy-and-hold chart shows how Synaptogenix performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Synaptogenix Market Price Analysis

Market price analysis indicators help investors to evaluate how Synaptogenix stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Synaptogenix shares will generate the highest return on investment. By understating and applying Synaptogenix stock market price indicators, traders can identify Synaptogenix position entry and exit signals to maximize returns.

Synaptogenix Return and Market Media

The median price of Synaptogenix for the period between Wed, Mar 13, 2024 and Tue, Jun 11, 2024 is 4.65 with a coefficient of variation of 5.14. The daily time series for the period is distributed with a sample standard deviation of 0.24, arithmetic mean of 4.66, and mean deviation of 0.18. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
WeWork Trading 216.5 percent Higher - Defense World
03/26/2024
2
Whats Going On With Synaptogenix Stock
04/04/2024
3
Acquisition by Bernstein Bruce of 800 shares of Synaptogenix at 5. subject to Rule 16b-3
04/08/2024
4
Synaptogenix increases psilocybin stake with PsygaBio - Green Market Report
04/10/2024
5
Synaptogenix Regains Compliance with Nasdaq Minimum Bid Price Requirement for Continued Listing
04/24/2024
6
Acquisition by Silverman Joshua of 800 shares of Synaptogenix at 5. subject to Rule 16b-3
05/10/2024
7
Acquisition by Robert Weinstein of 96000 shares of Synaptogenix subject to Rule 16b-3
06/07/2024

About Synaptogenix Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Synaptogenix or other stocks. Alpha measures the amount that position in Synaptogenix has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2021 2023 2024 (projected)
PTB Ratio31.820.130.12
Dividend Yield0.20.180.12

Synaptogenix Upcoming Company Events

As portrayed in its financial statements, the presentation of Synaptogenix's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Synaptogenix's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Synaptogenix's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Synaptogenix. Please utilize our Beneish M Score to check the likelihood of Synaptogenix's management manipulating its earnings.
19th of March 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

Build Portfolio with Synaptogenix

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Tools for Synaptogenix Stock Analysis

When running Synaptogenix's price analysis, check to measure Synaptogenix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Synaptogenix is operating at the current time. Most of Synaptogenix's value examination focuses on studying past and present price action to predict the probability of Synaptogenix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Synaptogenix's price. Additionally, you may evaluate how the addition of Synaptogenix to your portfolios can decrease your overall portfolio volatility.